Actinium Pharmaceuticals (ATNM)
(Delayed Data from AMEX)
$1.59 USD
-0.06 (-3.64%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.60 +0.01 (0.63%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Actinium Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ATNM 1.59 -0.06(-3.64%)
Will ATNM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ATNM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ATNM
Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year?
Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year?
ATNM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View
Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates
All You Need to Know About Actinium (ATNM) Rating Upgrade to Strong Buy
Other News for ATNM
Is ATNM likely to continue lower? 50 Day Moving Average Resistance shows up after dropping 3.64%
Is ATNM setting up for a drop? 20 Day Moving Average Resistance shows up after gaining 2.48%
ATNM Fell Below 50 Day Moving Average on September 17
ATNM Crossed Above 50 Day Moving Average on September 16
Is ATNM set to breakout? NR7 shows up after dropping 0.61%